|
PLRX Pliant Therapeutics Inc 1746473 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-22,371,000.00 |
| Balance Sheet |
|
Current Assets
|
$163,142,000.00 |
|
Assets
|
$189,881,000.00 |
|
Current Liabilities
|
$16,484,000.00 |
|
Liabilities
|
$42,955,000.00 |
|
Equity
|
$146,926,000.00 |
|
Shares Out
|
61920154.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-32,026,000.00 |
|
Investing Cash Flow
|
$11,390,000.00 |
| Market Analysis |
Market Cap
|
$69,350,572.48 |
|
Price
|
$1.12 |
|
BVPS
|
2.37 |
|
PB
|
0.47 |
|
EPS
|
-0.36 |
|
FCF
|
$-32,026,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:52 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:43 |
|
| Apr |
May |
Jun |
| 2026-03-11 |
-0.38 |
|
|
2026-05-11 |
-0.32 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-07 |
-0.71 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-06 |
-0.43 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view PLRX documents filed with the SEC.
PLRX Filings
Clear
